Skip to main content
. 2024 Sep;79:103472. doi: 10.1016/j.scr.2024.103472
Unique stem cell line identifier FSMi001-A
Alternative name(s) of stem cell line FSM-SPG31-2
Institution Department of Neurobiology and Molecular Medicine, IRCCS Fondazione Stella Maris, Calambrone (PI), Italy
Contact information of distributor Matteo Baggiani – matteo.baggiani@fsm.unipi.it
Devid Damiani – devid.damiani@fsm.unipi.it
Type of cell line hiPSC
Origin Human
Additional origin info required for human ESC or iPSC Age: 47 years
Sex: Female
Ethnicity: Caucasian
Cell Source Skin fibroblasts
Clonality Clonal
Method of reprogramming Episomal vectors encoding OCT4/sh-p53, SOX2/KLF4, EBNA-1, and L-MYC/LIN28
Genetic Modification NO
Type of Genetic Modification None
Evidence of the reprogramming transgene loss (including genomic copy if applicable) RT/qPCRs for plasmid-specific transcripts show no expression for reprogramming genes
Associated disease SPG31 (Spastic Paraplegia 31)
Gene/locus REEP1 (c.337C > T; p. Arg113*)
Date archived/stock date 03 July 2013
Cell line repository/bank https://hspcreg.eu/cell-line/FSMi001-A
Ethical approval Written informed consent was obtained from patient